The MarketWatch News Department was not involved in the creation of this content. A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and ...
Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...
A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate MONMOUTH JUNCTION, N.J., Feb. 9, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results